Maternal serum superoxide dismutase (SOD): A possible marker for screening Down syndrome affected pregnancies

Prenatal Diagnosis

Volumn 19, Issue 11, 1999, Pages 1058-1060

  Ognibene, Agostino ^a   Ciuti, Riccardo ^a   Tozzi, Paola ^a   Messeri, Gianni ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Down syndrome; Prenatal screening; SOD; Superoxide dismutase

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; MARKER; SUPEROXIDE DISMUTASE;

ADULT; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DOWN SYNDROME; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; MATERNAL SERUM; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

EID: 0032731765     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0223(199911)19:11<1058::aid-pd685>3.0.co;2-s     Document Type: Article

References (13)

1. Baeteman MA, Mattel MG, Baret A, Gamerre M, Mattei JF. 1985. Immunoreactive SOD-1 in amniotic fluid, amniotic cells and fibroblasts from trisomy 21 fetus. Acta Paediatr Scand 74: 697-700.
2. Bannister JV, Bannister WH, Rotilio G. 1987. Aspects of the structure, function, and application of superoxide dismutase. CRC Crit Rev Biochem 22: 111-180.
3. Beckman G, Lundgren E, Tarnvik A. 1973. Superoxide dismutase isozymes in different human tissues, their genetic control and intracellular localization. Hum Hered 23: 338-345.
4. Cuckle HS, Wald NJ, Thompson SG. 1987. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94: 387-402.
5. Frants RR, Eriksson AW, Jongloet PH, Hamers AJ. 1975. Superoxide dismutase in Down's syndrome. Lancet 2: 42-43.
6. Neveux LM, Palomaki GE, Larrive DA, Knight GJ, Haddow JE. 1996. Refinement in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn 16: 1115-1119.
7. Paoletti F, Mocali A. 1990. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Meth Enzymol 186: 208-220.
8. Poissonier M, Saint-Paul B, Dutrillax B, Chaisaigne M, Gruyer P, Blignieres-Strouk G. 1976. Trisomie 21 partielle (21q21-21q22.2). Ann Génét 19: 69-73.
9. Porstmann T, Wietschke R, Cobet G, Lorenz K, Grunow R, Jahn S, Bollmann R, Stamminger G, von Baehr R. 1990. Immunochemical quantification of Cu/Zn superoxide dismutase in prenatal diagnosis of Down's syndrome. Hum Genet 85: 362-366.
10. Sinet PM. 1982. Metabolism of oxygen derivatives in Down's syndrome. Ann NY Acad Sci 396: 83-94.
11. Sinet PM, Couturier J, Dutrillaux B, Poissonier M, Raoul O, Rethore MO, Allerd D, Lejeune J, Jerome H. 1976. Trisomy 21 and superoxide dismutase (IPO-A). Exp Cell Res 97: 47-55.
12. Stein TN, Keen CL, Lonnerdal B, Hurley LS. 1982. Effect of sample preparaction on analysis of superoxide dismutase activity and isoenzymes. J Inorgan Biochem 16: 71-77.
13. Tan Y, Tischfeld J, Ruddle F. 1973. The linkage of genes for the human interferon-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21. J Exp Med 137: 317-330.